Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc. ...Middle East

Poseida stockholders to receive up to $13.00 per share in cash, comprised of $9.00 per share in cash at closing and a non-tradeable contingent value right (CVR) to receive up to an aggregate of $4.00 per share in cash; transaction represents total equity value of up to $1.5 billion...

Read More Details
Finally We wish PressBee provided you with enough information of ( Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc. )

Also on site :

• Amazon Has ‘Awesome’ $30 Arch Support Flip Flops on Sale for $12, and Reviewers Are ‘Stunned’ How Comfortable They Are
• Today’s NYT ‘Strands’ Hints, Spangram and Answers for Saturday, June 7
• Pop Icon Looks Unrecognizable After Ditching '80s Glam in Makeup-Free Selfie